Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: Synthesis, structure-activity relationships, and X-ray crystallographic studies

被引:188
作者
Wen, Xiaoan [1 ]
Sun, Hongbin [1 ]
Liu, Jun [2 ]
Cheng, Keguang [1 ]
Zhang, Pu [1 ]
Zhang, Liying [1 ]
Hao, Jia [1 ]
Zhang, Luyong [2 ]
Ni, Peizhou [1 ]
Zographos, Spyros E. [3 ]
Leonidas, Demetres D. [3 ]
Alexacou, Kyra-Melinda [3 ]
Gimisis, Thanasis [4 ]
Hayes, Joseph M. [3 ]
Oikonomakos, Nikos G. [3 ]
机构
[1] China Pharmaceut Univ, Coll Pharm, Ctr Drug Discovery, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210038, Peoples R China
[3] Natl Hellen Res Fdn, Inst Organ & Pharmaceut Chem, Athens 11635, Greece
[4] Univ Athens, Dept Chem, Organ Chem Lab, Athens 15771, Greece
关键词
D O I
10.1021/jm8000949
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Twenty-five naturally occurring pentacyclic triterpenes, 15 of which were synthesized in this study, were biologically evaluated as inhibitors of rabbit muscle glycogen phosphorylase a (GPa). From SAR studies, the presence of a sugar moiety in triterpene saponins resulted in a markedly decreased activity (7, 18-20) or no activity (21, 22). These saponins, however, might find their value as potential natural prodrugs which are much more water-soluble than their corresponding aglycones. To elucidate the mechanism of GP inhibition, we have determined the crystal structures of the GPb-asiatic acid and GPb-maslinic acid complexes. The X-ray analysis indicates that the inhibitors bind at the allosteric activator site, where the physiological activator AMP binds. Pentacyclic triterpenes represent a promising class of multiple-target antidiabetic agents that exert hypoglycemic effects, at least in part, through GP inhibition.
引用
收藏
页码:3540 / 3554
页数:15
相关论文
共 80 条
[11]   Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors [J].
Birch, Alan M. ;
Kenny, Peter W. ;
Oikonomakos, Nikos G. ;
Otterbein, Ludovic ;
Schofield, Paul ;
Whittamore, Paul R. O. ;
Whalley, Dave P. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) :394-399
[12]   Specific features of glycogen metabolism in the liver [J].
Bollen, M ;
Keppens, S ;
Stalmans, W .
BIOCHEMICAL JOURNAL, 1998, 336 :19-31
[13]   Synthesis of β-boswellic acid analogues with a carboxyl group at C-17 isolated from the bark of Schefflera octophylla [J].
Bore, L ;
Honda, T ;
Gribble, GW .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (19) :6278-6282
[14]   A PARTIAL SYNTHESIS OF MASLINIC ACID [J].
CAGLIOTI, L ;
CAINELLI, G .
TETRAHEDRON, 1962, 18 (SEP) :1061-&
[15]   Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase [J].
Chen, J ;
Liu, J ;
Zhang, LY ;
Wu, GZ ;
Hua, WY ;
Wu, XM ;
Sun, HB .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (11) :2915-2919
[16]   GLUCOSIDATION OF OLEANOLIC AND URSOLIC ACIDSUNDER PHASE-TRANSFER CATALYSIS [J].
CHERITI, A ;
BALANSARD, G .
NATURAL PRODUCT LETTERS, 1995, 7 (01) :47-50
[17]   Kinetic and crystallographic studies on 2-(β-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b.: Evidence for a new binding site [J].
Chrysina, ED ;
Kosmopoulou, MN ;
Tiraidis, C ;
Kardakaris, R ;
Bischler, N ;
Leonidas, DD ;
Hadady, Z ;
Somsak, L ;
Docsa, T ;
Gergely, P ;
Oikonomakos, NG .
PROTEIN SCIENCE, 2005, 14 (04) :873-888
[18]   A practical synthesis of betulinic acid [J].
Csuk, Rene ;
Schmuck, Kianga ;
Schaefer, Renate .
TETRAHEDRON LETTERS, 2006, 47 (49) :8769-8770
[19]   Bevirimat - Anti-HIV agent viral maturation inhibitor [J].
Dimeglumine, Bevirimat .
DRUGS OF THE FUTURE, 2007, 32 (01) :7-11
[20]   Pharmacological activities of natural triterpenoids and their therapeutic implications [J].
Dzubak, Petr ;
Hajduch, Marian ;
Vydra, David ;
Hustova, Alica ;
Kvasnica, Miroslav ;
Biedermann, David ;
Markova, Lenka ;
Urban, Milan ;
Sarek, Jan .
NATURAL PRODUCT REPORTS, 2006, 23 (03) :394-411